Literature DB >> 18776767

Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.

William B Slayton1, Milin Patel, Martha Sola-Visner, Neil Harris, Angela Rivers, Robert R Montgomery, Kenneth D Friedman.   

Abstract

We report a child with thrombocytopenia since birth, circulating platelet agglutinates, and a tendency to bleed. A bone marrow aspirate revealed large platelet clumps within the bone marrow and megakaryocyte nuclei surrounded by halos of clumped platelets. Laboratory evaluation revealed type 2B von Willebrand disease. Gene sequencing revealed a G to C mutation at base 3923 of the VWF gene. This mutation was previously described in a family with circulating platelet clumps and abnormal megakaryopoiesis with release of clumped platelets in culture. This same mutation was previously described in a family with circulating platelet aggregates and abnormalities of platelet release from megakaryocytes in vitro. Presence of megakaryocytes with halos of clumped platelets in our patient suggests that platelet agglutinate occurs in the bone marrow in some type 2B von Willebrand disease patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776767      PMCID: PMC5592795          DOI: 10.1097/MPH.0b013e31817541cd

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  21 in total

Review 1.  Regulation of RUNX1 transcriptional function by GATA-1.

Authors:  Kamaleldin E Elagib; Adam N Goldfarb
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

2.  Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease.

Authors:  P Nurden; F Chretien; C Poujol; J Winckler; A Borel-Derlon; A Nurden
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 3.  Molecular and transcriptional regulation of megakaryocyte differentiation.

Authors:  R A Shivdasani
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

4.  Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences.

Authors:  B A Payne; R V Pierre
Journal:  Mayo Clin Proc       Date:  1984-02       Impact factor: 7.616

5.  Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.

Authors:  Alessandro M Vannucchi; Alessandro Pancrazzi; Paola Guglielmelli; Simonetta Di Lollo; Costanza Bogani; Gianna Baroni; Lucia Bianchi; Anna Rita Migliaccio; Alberto Bosi; Francesco Paoletti
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

Review 6.  The physiology of platelet production.

Authors:  D J Kuter
Journal:  Stem Cells       Date:  1996       Impact factor: 6.277

7.  Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA.

Authors:  M J Mant; J C Doery; J Gauldie; H Sims
Journal:  Scand J Haematol       Date:  1975-10

8.  Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice.

Authors:  K Onodera; J A Shavit; H Motohashi; M Yamamoto; J D Engel
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

9.  Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia.

Authors:  F Silvestri; L Virgolini; C Savignano; F Zaja; M Velisig; M Baccarani
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

Review 10.  Management of inherited von Willebrand disease in 2007.

Authors:  Augusto B Federici; Pier Mannuccio Mannucci
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

View more
  3 in total

1.  Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.

Authors:  Paquita Nurden; Alan T Nurden; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Augusto B Federici
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

2.  Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance.

Authors:  Kathleen Freson
Journal:  Haematologica       Date:  2019-07       Impact factor: 9.941

3.  2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines.

Authors:  Maha Othman; Emmanuel J Favaloro
Journal:  Res Pract Thromb Haemost       Date:  2021-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.